Scholarly publications and presentations by Rochester Regional Health's Internal Medicine department authors.
Submissions from 2024
6-18-2024 Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab, Anthony Ocon, Rochester Regional Health; Eduardo Avalos Sugastti, Rochester Regional Health; and Nananamibia Duffy, Rochester Regional Health
6-16-2024 Impact of index admission cholecystectomy vs interval cholecystectomy on readmission rate in acute cholangitis: National Readmission Database survey, Abdullah Sohail, Department of Internal Medicine, University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa, IA 52242, United States., Ahmed Shehadah, Rochester Regional Health, Ammad Chaudhary, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, United States., et al.
6-7-2024 Health for all: Primary care facility localization in Lesotho using qualitative research and GIS, Mariam A.O. Mostafa, Rochester Regional Health, Joy Oluwaseun Ogunmuyiwa, Kathryne Appleby Tenney, et al.
6-1-2024 Apixaban versus warfarin for primary thromboprophylaxis in patients with multiple myeloma undergoing immunomodulatory treatment, Yu-Cheng Chang, Department of Medicine, Danbury Hospital, Danbury, CT, Cho-Han Chiang, Department of Medicine, Mount Auburn Hospital, Cambridge, Massachusetts, USA, Zhiting Tang, Rochester Regional Health, et al.
6-1-2024 Association of posterior reversible encephalopathy syndrome with proteasome inhibitors approved for multiple myeloma: Analysis of FAERS database, Harkarandeep Singh, Rochester Regional Health, Uttamjot Kaur, Dayanand Medical College, Ludhiana, India, Niraj Neupane, Rochester Regional Health, et al.
6-1-2024 Chalazion associated with proteasome inhibitors approved for multiple myeloma: Analysis of FAERS database, Harkarandeep Singh, Rochester Regional Health, Uttamjot Kaur, Dayanand Medical College, Ludhiana, India, Niraj Neupane, Rochester Regional Health, et al.
6-1-2024 Clinical, phenotypic, and genotypic characteristics of ESBL-producing Salmonella enterica bloodstream infections from Qatar, Wael Goravey, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar., Clement K. Tsui, Infectious Diseases Research Laboratory, National Centre for Infectious Diseases, Singapore., Gawahir A. Ali, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar., et al.
6-1-2024 COVID-19 associated encephalopathy, Mahrukh Tariq and Zauraiz Anjum, Rochester Regional Health
6-1-2024 Diagnosing aceruloplasminemia: navigating through red herrings, Zeni Kharel, Rochester Regional Health; Himal Kharel, Rochester Regional Health; and Pradyumna D. Phatak, Rochester Regional Health
6-1-2024 Exploring the correlation between colonic mural thickening on computed tomography and endoscopic findings: Insights from a retrospective study, Ahmed Shehadah, Rochester Regional Health, Dileepa Chathuranga, Rochester Regional Health, Ali Jaan, Rochester Regional Health, et al.
6-1-2024 Factors influencing the mortality risk of heart failure in patients receiving antineoplastic immunotherapy: A national inpatient database study 2016-2020, Purva Shah, Rochester Regional Health, Abdullah A. Orakzai, Rochester Regional Health, Himal Kharel, Rochester Regional Health, et al.
6-2024 First reported use of immune checkpoint inhibitor for treatment of cancer in a patient with acquired hemophilia A, Mariam A.O. Mostafa, Rochester Regional Health, Sheref Elseidy, Rochester Regional Health, Reham Ali Metwally, et al.
6-1-2024 From constriction to dilation, efficacy & safety of endoscopic balloon dilation in patients in inflammatory bowel disease: A systematic review & meta-analysis, Vishali Moond, Archit Garg, Ameya Kasture, et al.
6-1-2024 Helicobacter pylori infection and risk of multiple sclerosis: an updated meta-analysis, Sangharsha Thapa, Jacobs Comprehensive MS Treatment and Research Center,, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA., Abhinav Bhattarai, Institute of Medicine, Tribhuvan University, Maharajgunj, 44600, Nepal., Sangam Shah, Institute of Medicine, Tribhuvan University, Maharajgunj, 44600, Nepal., et al.
6-1-2024 Hospitalization outcomes of patients with colorectal cancer (CRC) admitted with Clostridioides difficile colitis, Aditya Sanjeevi, Rochester Regional Health, Samikchhya Keshary Bhandari, Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal., Himal Kharel, Rochester Regional Health, et al.
6-1-2024 Is essential thrombocytosis associated with worse outcomes in patients with stroke? Results from 2016-2020 National Inpatient Sample study, Himal Kharel, Rochester Regional Health, Samikchhya Keshary Bhandari, Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal., Zeni Kharel, Rochester Regional Health, et al.
6-1-2024 Learning curve for colorectal endoscopic submucosal dissection (ESD) among endoscopists without prior ESD experience - A systematic review and meta-analysis, Abdul Mohammed, Saurabh Chandan, Jay Bapaye, Rochester Regional Health, et al.
6-1-2024 Machine Learning-Based Prediction Models for Clostridioides difficile Infection: A Systematic Review, Raseen Tariq, Mayo Clinic, Rochester, Minnesota, USA., Sheza Malik, Rochester Regional Health, Renisha Redij, Trinity Health Livonia Hospital, Michigan, Livonia, USA., et al.
6-1-2024 Navigating narrow paths, efficacy & safety of endoscopic stricturotomy in inflammatory bowel disease patients: A systemic review & meta-analysis, Vishali Moond, Archit Garg, Ameya Kasture, et al.
6-2024 Plagiarism, Richard Alweis, Rochester Regional Health and Nagesh Jadhav, Rochester Regional Health
6-1-2024 Recurrent hypo-attenuated leaflet thickening after TAVR: Clinical implications, Andrew Takla, Rochester Regional Health; Kirolus Sourial, Rochester Regional Health; and Gaurav Sharma, Rochester Regional Health
6-1-2024 Safety and efficacy of EUS-guided porto-systemic pressure gradient measurement – An updated systematic review and meta-analysis, Jay Bapaye, Rochester Regional Health, Subhash Garikipati, Dushyant Singh Dahiya, et al.
6-1-2024 Systematic Review with Meta-analysis: Efficacy and Safety of Upadacitinib in Managing Moderate-to-Severe Crohn's Disease and Ulcerative Colitis, Chengu Niu, Rochester Regional Health, Jing Zhang, Rainier Springs, Vancouver, WA, USA., Mahesh Nepal, Rochester Regional Health, et al.
6-1-2024 The association between osimertinib and nutritional deficiency among patients with non-small cell lung cancer, Zhiting Tang, Rochester Regional Health, Cho-Han Chiang, Department of Medicine, Mount Auburn Hospital, Cambridge, Massachusetts, USA, Yu-Cheng Chang, Department of Medicine, Danbury Hospital, Danbury, CT, et al.
6-1-2024 The impact of glucagon-like peptide-1 receptor agonists on proteasome inhibitor-associated cardiotoxicity in patients with multiple myeloma, Yu-Cheng Chang, Department of Medicine, Danbury Hospital, Danbury, CT, Cho-Han Chiang, Department of Medicine, Mount Auburn Hospital, Cambridge, Massachusetts, USA, Zhiting Tang, Rochester Regional Health, et al.